Noveome Biotherapeutics's last reported valuation, Apr 2019. Nothing priced has surfaced since.
- ·Watch Noveome Biotherapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Noveome Biotherapeutics funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2023 | Early Stage VC | $36.2M | ▮ | ▮ |
| Sep 2020 | Seed Round | $870K | ▮ | ▮ |
| Jan 2018 | Early Stage VC | $15.0M | ▮ | ▮ |
| Dec 2015 | Seed Round | $2.2M | ▮ | ▮ |
Membership and data by Private Market View
Noveome Biotherapeutics valuation
Noveome Biotherapeutics's last reported valuation was $200 million in Apr 2019. No priced round, secondary trade or fund mark has surfaced since.
How much has Noveome Biotherapeutics raised?
Noveome Biotherapeutics has raised $78.7 million across 4 recorded rounds since 2015. The largest was an $870,000 seed round in Sep 2020; the most recent was a $36.2 million early-stage round in Aug 2023.
Noveome Biotherapeutics has filed 6 Form Ds with the SEC since 2016, most recently in Aug 2024 ($36.2 million sold to 66 investors).
How Noveome Biotherapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Noveome Biotherapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Noveome Biotherapeutics
- What is Noveome Biotherapeutics worth?
- Noveome Biotherapeutics is valued at $200.0M as of Oct 2026. Noveome Biotherapeutics's last reported valuation, Apr 2019. Nothing priced has surfaced since.
- How much has Noveome Biotherapeutics raised?
- Noveome Biotherapeutics has raised $78.7M in total funding across 4 recorded rounds.
- When did Noveome Biotherapeutics last raise?
- Noveome Biotherapeutics last raised in Aug 2023 (Early Stage VC), raising $36.2M.